氯雷他定和西替利嗪治疗荨麻疹的多中心试验。
A multicentric trial of loratadine and cetirizine in urticaria.
作者信息
Thomas J, Pandhi R K, Oberoi C, Bandopadhyay D, Rajendran S C, Menon S S, Marquis S
机构信息
Skin Specialist 2, West Mada Church Road, Royapuram, Madras 600013, India.
出版信息
Indian J Dermatol Venereol Leprol. 1998 Jan-Feb;64(1):12-6.
PMID:20921702
Abstract
Two hundred and ten patients with chronic urticaria were divided into two groups; one group was treated with Loratadine 10mg daily while the other with cetirizine 10mg daily. The total duration of treatment was four weeks. Pretreatment and post-treatment evaluations were made. It was noticed that loratadine was superior to cetirizine in terms of a rapid onset of actions, overall clinical efficacy and minimal side effects.
摘要
210例慢性荨麻疹患者被分为两组；一组每日服用10毫克氯雷他定，另一组每日服用10毫克西替利嗪。治疗总时长为四周。进行了治疗前和治疗后的评估。结果发现，氯雷他定在起效速度、总体临床疗效和最小副作用方面优于西替利嗪。
Zotero 插件